Liver Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 5 (May)

1. Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients.
   Am J Surg, 189(5): 552-7; discussion 557. [Abstract] [Full-text]
2. Impact of aberrant arterial anatomy and location of anastomosis on technical outcomes after liver transplantation.
   J Gastrointest Surg, 9(5): 672-8. [Abstract] [Full-text]
3. Ischaemic preconditioning in transplantation and major resection of the liver.
   Br J Surg, 92(5): 528-38. [Abstract] [Full-text]
4. Laparoscopic organ retrieval for living donor liver transplantation does not prevent graft injury.
   Transplant Proc, 37(3): 1625-7. [Abstract] [Full-text]
5. Pediatric renal transplantation: 13 years of experience--report from the Chilean Cooperative Multicenter Group.
   Transplant Proc, 37(3): 1569-73. [Abstract] [Full-text]
6. ABO-incompatible liver transplantation: a new therapeutic option for patients with acute liver failure in Chile.
   Transplant Proc, 37(3): 1567-8. [Abstract] [Full-text]
7. Circadian variability of blood pressure in liver transplant recipients without antihypertensive therapy.
   Transplant Proc, 37(3): 1515-6. [Abstract] [Full-text]
8. Mycotic pseudoaneurysms after liver transplantation.
   Transplant Proc, 37(3): 1512-4. [Abstract] [Full-text]
9. Mycophenolate mofetil-induced neutropenia in liver transplantation.
   Transplant Proc, 37(3): 1509-11. [Abstract] [Full-text]
10. Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.
    Transplant Proc, 37(3): 1507-8. [Abstract] [Full-text]
11. Liver transplantation at the Cuban Center for Medical and Surgical Research.
    Transplant Proc, 37(3): 1505-6. [Abstract] [Full-text]
12. Psychological adaptation of liver transplant recipients.
    Transplant Proc, 37(3): 1502-4. [Abstract] [Full-text]
13. Preoperative factors and models predicting mortality in liver transplantation.
    Transplant Proc, 37(3): 1499-501. [Abstract] [Full-text]
14. Lack of association of recipient MCP-1 gene promoter polymorphism with acute graft rejection after orthotopic liver transplantation.
    Transplant Proc, 37(3): 1496-8. [Abstract] [Full-text]
15. Doppler ultrasonography for the assessment of tumor necrosis after percutaneous ethanol injection prior to liver transplantation as adjuvant therapy of hepatocellular carcinoma.
    Transplant Proc, 37(3): 1493-5. [Abstract] [Full-text]
16. Results of liver transplantation in patients with previous portosystemic shunts.
    Transplant Proc, 37(3): 1491-2. [Abstract] [Full-text]
17. Liver transplant results for hepatocellular carcinoma applying strict preoperative selection criteria.
    Transplant Proc, 37(3): 1488-90. [Abstract] [Full-text]
18. Prevalence of hepatitis C virus genotypes in a Spanish liver transplant unit.
    Transplant Proc, 37(3): 1486-7. [Abstract] [Full-text]
19. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Transplant Proc, 37(3): 1484-5. [Abstract] [Full-text]
20. Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis.
    Transplant Proc, 37(3): 1482-3. [Abstract] [Full-text]
21. Therapy of intractable pruritus with MARS.
    Transplant Proc, 37(3): 1480-1. [Abstract] [Full-text]
22. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Transplant Proc, 37(3): 1477-9. [Abstract] [Full-text]
23. Acute fatty liver of pregnancy -- an underlying condition for herpes simplex type 2 fulminant hepatitis necessitating liver transplantation.
    Z Gastroenterol, 43(5): 451-4. [Abstract] [Full-text]
24. Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explant livers and clinical outcome.
    Cancer Biother Radiopharm, 20(2): 209-14. [Abstract] [Full-text]
25. Knot in the cava--an unusual complication of swan-ganz catheters.
    Eur J Vasc Endovasc Surg, 29(6): 651-3. [Abstract] [Full-text]
26. Outcome of hepatic artery reconstruction in liver transplantation with an iliac arterial interposition graft.
    Clin Transplant, 19(3): 399-405. [Abstract] [Full-text]
27. Extended survival by urgent liver retransplantation after using a first graft with metastasis from initially unrecognized donor sarcoma.
    Am J Transplant, 5(6): 1559-61. [Abstract] [Full-text]
28. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation.
    Am J Transplant, 5(6): 1397-404. [Abstract] [Full-text]
29. Impact of right lobe with middle hepatic vein graft in living-donor liver transplantation.
    Am J Transplant, 5(6): 1339-46. [Abstract] [Full-text]
30. The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation.
    Am J Transplant, 5(6): 1264-75. [Abstract] [Full-text]
31. Survival after pediatric liver transplantation: why does living donation offer an advantage?
    Arch Surg, 140(5): 465-70; discussion 470-1. [Abstract] [Full-text]
32. Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease.
    Arch Surg, 140(5): 459-64; discussion 464. [Abstract] [Full-text]
33. A case of suspected severe pulmonary embolism in a living-related liver transplantation donor.
    J Clin Anesth, 17(3): 218-20. [Abstract] [Full-text]
34. Systemic vasodilation is a predominant cause of hypotension in a patient with familial amyloid polyneuropathy during liver transplantation.
    J Clin Anesth, 17(3): 202-4. [Abstract] [Full-text]
35. Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation.
    J Clin Pharmacol, 45(6): 666-73. [Abstract] [Full-text]
36. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    J Clin Virol, 33(2): 138-44. [Abstract] [Full-text]
37. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.
    Liver Int, 25(3): 536-41. [Abstract] [Full-text]
38. Replacing calcineurin inhibitors with mTOR inhibitors in children.
    Pediatr Transplant, 9(3): 391-7. [Abstract] [Full-text]
39. Transfusion requirements during cadaveric and living donor pediatric liver transplantation.
    Pediatr Transplant, 9(3): 332-7. [Abstract] [Full-text]
40. Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein.
    Pediatr Transplant, 9(3): 315-23. [Abstract] [Full-text]
41. Single pretransplant bolus of recombinant activated factor VII ameliorates influence of risk factors for blood loss during orthotopic liver transplantation.
    Pediatr Transplant, 9(3): 299-304. [Abstract] [Full-text]
42. Hepatic venous reconstruction in pediatric living-related donor liver transplantation--experience of a single center.
    Pediatr Transplant, 9(3): 293-8. [Abstract] [Full-text]
43. Successful outcome following transplantation of an injured liver from a nonheart beating donor.
    Transpl Int, 18(6): 724-6. [Abstract] [Full-text]
44. Older liver graft transplantation, cholestasis and synthetic graft function.
    Transpl Int, 18(6): 709-15. [Abstract] [Full-text]
45. Liver transplantation in patients with hepatic hydrothorax.
    Transpl Int, 18(6): 672-5. [Abstract] [Full-text]
46. Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia.
    Transpl Int, 18(6): 664-7. [Abstract] [Full-text]
47. Living-related liver transplantation for Wilson's disease.
    Transpl Int, 18(6): 651-6. [Abstract] [Full-text]
48. Bile duct complications after liver transplantation.
    Transpl Int, 18(6): 627-42. [Abstract] [Full-text]
49. Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation.
    Radiology, 235(3): 1078-83. [Abstract] [Full-text]
50. Living donor candidates for right hepatic lobe transplantation: evaluation at CT cholangiography--initial experience.
    Radiology, 235(3): 899-904. [Abstract] [Full-text]
51. Is there any difference in anesthetic management of biliary atresia and glycogen storage disease patients undergoing liver transplantation?
    J Surg Res, 126(1): 82-5. [Abstract] [Full-text]
52. Endometrial adenocarcinoma after liver transplantation.
    J Obstet Gynaecol Res, 31(3): 224-6. [Abstract] [Full-text]
53. Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease.
    Magn Reson Imaging, 23(4): 557-62. [Abstract] [Full-text]
54. Severe hearing loss after liver transplantation.
    Transplant Proc, 37(4): 1918-9. [Abstract] [Full-text]
55. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
    Transplant Proc, 37(4): 1912-4. [Abstract] [Full-text]
56. Relationship between immunosuppression and osteoporosis in an outpatient liver transplant clinic.
    Transplant Proc, 37(4): 1910-1. [Abstract] [Full-text]
57. Kaposi sarcoma in solid organ transplant recipients: a single center report.
    Transplant Proc, 37(4): 1905-9. [Abstract] [Full-text]
58. No influence of immunosuppression on insulin sensitivity and beta-cell function in living donor liver transplantation.
    Transplant Proc, 37(4): 1861-4. [Abstract] [Full-text]
59. Initial dosage adjustment for oral administration of tacrolimus using the intestinal MDR1 level in living-donor liver transplant recipients.
    Transplant Proc, 37(4): 1728-9. [Abstract] [Full-text]
60. Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure.
    Transplant Proc, 37(4): 1720-1. [Abstract] [Full-text]
61. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
    Transplant Proc, 37(4): 1718-9. [Abstract] [Full-text]
62. The influence of late acute rejection episodes on long-term graft outcome after liver transplantation.
    Transplant Proc, 37(4): 1716-7. [Abstract] [Full-text]
63. Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation.
    Transplant Proc, 37(4): 1713-5. [Abstract] [Full-text]
64. Influence of methicillin-resistant Staphylococcus aureus carrier status in liver transplant recipients.
    Transplant Proc, 37(4): 1710-2. [Abstract] [Full-text]
65. Long-term outcome of immunosuppression withdrawal after liver transplantation.
    Transplant Proc, 37(4): 1708-9. [Abstract] [Full-text]
66. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
    Transplant Proc, 37(4): 1705-7. [Abstract] [Full-text]
67. Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.
    Transplant Proc, 37(4): 1703-4. [Abstract] [Full-text]
68. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Transplant Proc, 37(4): 1700-2. [Abstract] [Full-text]
69. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
    Transplant Proc, 37(4): 1697-9. [Abstract] [Full-text]
70. Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis.
    Transplant Proc, 37(4): 1695-6. [Abstract] [Full-text]
71. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Transplant Proc, 37(4): 1691-2. [Abstract] [Full-text]
72. Blockade of fibronectin-alpha4beta1 adhesive interactions down-regulates cyclooxygenase-2 inducible nitric oxide synthase and prolongs recipient survival in a 24-hour model of cold hepatic ischemia-reperfusion injury.
    Transplant Proc, 37(4): 1682-3. [Abstract] [Full-text]
73. Ischemia and reperfusion injury in liver transplantation.
    Transplant Proc, 37(4): 1653-6. [Abstract] [Full-text]
74. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Clin Ther, 27(4): 463-9. [Abstract] [Full-text]
75. Cryopreserved iliac artery is indispensable interposition graft material for middle hepatic vein reconstruction of right liver grafts.
    Liver Transpl, 11(6): 644-9. [Abstract] [Full-text]
76. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Liver Transpl, 11(6): 700-4. [Abstract] [Full-text]
77. Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor.
    Liver Transpl, 11(6): 696-9. [Abstract] [Full-text]
78. Dynamic left ventricular outflow tract obstruction in an orthotopic liver transplant recipient.
    Liver Transpl, 11(6): 692-5. [Abstract] [Full-text]
79. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.
    Liver Transpl, 11(6): 627-34; discussion 610-1. [Abstract] [Full-text]
80. Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis.
    Liver Transpl, 11(6): 684-91. [Abstract] [Full-text]
81. Liver transplant recipient selection: MELD vs. clinical judgment.
    Liver Transpl, 11(6): 621-6. [Abstract] [Full-text]
82. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem.
    Liver Transpl, 11(6): 679-83. [Abstract] [Full-text]
83. Impact of donor gender on male rat recipients of small-for-size liver grafts.
    Liver Transpl, 11(6): 669-78. [Abstract] [Full-text]
84. New-onset diabetes after liver transplantation: from pathogenesis to management.
    Liver Transpl, 11(6): 612-20. [Abstract] [Full-text]
85. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Liver Transpl, 11(6): 656-62. [Abstract] [Full-text]
86. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
    Hepatology, 41(6): 1282-9. [Abstract] [Full-text]

© 2005-2008 Liver Transplant Research Today. All Rights Reserved.